Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04160546
Title Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Fundacion CRIS de Investigacion para Vencer el Cáncer

chronic myeloid leukemia


Aspirin + Ponatinib

Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST